Clinical trials
Phase 2/3 Prostatic Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2005 | 1 |
| 2006 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Terminated | 4 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Michael Graham PhD, MD | 3 |
| Novartis Pharmaceuticals | 2 |
| University of California, San Francisco | 2 |
| Abbott | 1 |
| Andrei Iagaru | 1 |
| Centers for Disease Control and Prevention | 1 |
| Columbia University | 1 |
| Dana-Farber Cancer Institute | 1 |
| EDAP TMS S.A. | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 36 |
| Prostatic Neoplasms, Castration-Resistant | 3 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Agnosia | 1 |
| Bone Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.